Difference between revisions of "DBP1:Main"
From NAMIC Wiki
| Line 10: | Line 10: | ||
| | | | ||
{| | {| | ||
| − | | colspan="2" width="100px" align="left" valign="top" | [[Image:Niethammer-MICCAI2007-fig1.png | + | | colspan="2" width="100px" align="left" valign="top" | [[Image:Niethammer-MICCAI2007-fig1.png|200px|DWI Outlier Rejection]] |
| width="250pt" valign="top" | Marc Niethammer, Sylvain Bouix, Santiago Aja-Fernández, Carl-Fredrik Westin, Martha E. Shenton. | | width="250pt" valign="top" | Marc Niethammer, Sylvain Bouix, Santiago Aja-Fernández, Carl-Fredrik Westin, Martha E. Shenton. | ||
Revision as of 17:23, 12 December 2007
Home < DBP1:MainBack to NA-MIC Cores
| ||||||
DBP 1 Overview
The NA-MIC Driving Biological Problems (DBP) Core 3.1 identified key biological problems to drive NA-MIC projects from 2004 to 2007. The DBP 1 projects involved a range of clinical studies aimed at building and using the NA-MIC Toolkit to address issues specifically relating to schizophrenia. The following links provided a detailed overview of the work accomplished by DBP 1 sites.
DBP 1 Projects - Organized by Site
DBP 1 Projects - Organized by Subject Matter
Principal Investigators
The PI's of these groups are also PI's of the following NIH institutes:
- Andy Saykin (Dartmouth): R01AG019771, R01CA101318
- Martha Shenton (Harvard PNL): R01MH050740, K05MH070047
- Steven Potkin (Irvine): U24RR021992, P20RR020837
- Jim Kennedy (Toronto): P01MH056193
